• Mon, December 12, 2022

by: WOPRAI

Edward Tenthoff Initiated (XFOR) at Buy and Held Target at $3 on, Dec 12th, 2022

by: WOPRAI

Steve Fleishman Upgraded (SO) to Buy and Held Target at $76 on, Dec 12th, 2022

by: WOPRAI

Edward White Maintained (SNDX) at Strong Buy with Increased Target to $33 on, Dec 12th, 2022

by: WOPRAI

Madhu Kumar Maintained (SNDX) at Strong Buy with Increased Target to $39 on, Dec 12th, 2022

by: WOPRAI

Arvind Ramnani Downgraded (ACN) to Sell on, Dec 12th, 2022

by: WOPRAI

Carter Gould Maintained (ACLX) at Buy with Increased Target to $38 on, Dec 12th, 2022

by: WOPRAI

Gil Blum Maintained (ACLX) at Strong Buy with Increased Target to $35 on, Dec 12th, 2022

by: WOPRAI

Joseph France Upgraded (ACHC) to Strong Buy and Held Target at $95 on, Dec 12th, 2022

by: WOPRAI

Ben Hendrix Maintained (ACHC) at Buy with Decreased Target to $93 on, Dec 12th, 2022

by: WOPRAI

Mark Massaro Initiated (BNGO) at Strong Buy and Held Target at $35 on, Dec 12th, 2022

by: WOPRAI

Swayampakula Ramakanth Initiated (AFMD) at Strong Buy and Held Target at $60 on, Dec 12th, 2022

by: WOPRAI

Daina Graybosch Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022

by: WOPRAI

Do Kim Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022

by: WOPRAI

James Shin Maintained (AFMD) at Buy with Decreased Target to $70 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (ADP) at Strong Buy with Increased Target to $285 on, Dec 12th, 2022

by: WOPRAI

Joseph Catanzaro Initiated (ACRV) at Buy and Held Target at $25 on, Dec 12th, 2022

by: WOPRAI

Akash Tewari Initiated (ACRV) at Strong Buy and Held Target at $17 on, Dec 12th, 2022

by: WOPRAI

Joseph Thome Initiated (ACRV) at Buy on, Dec 12th, 2022

by: WOPRAI

Tyler Radke Maintained (ADBE) at Hold with Decreased Target to $337 on, Dec 12th, 2022

by: WOPRAI

Karl Keirstead Maintained (ADBE) at Hold with Increased Target to $350 on, Dec 12th, 2022

by: WOPRAI

Joanne Wuensch Downgraded (BAX) to Hold and Decreased Target to $58 on, Dec 12th, 2022

by: WOPRAI

Seth Seifman Maintained (BA) at Buy with Increased Target to $200 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Upgraded (BBY) to Hold and Increased Target to $83 on, Dec 12th, 2022

by: WOPRAI

Joanne Wuensch Upgraded (BDX) to Hold and Increased Target to $250 on, Dec 12th, 2022

by: WOPRAI

Andrew Berens Maintained (BGNE) at Buy with Increased Target to $236 on, Dec 12th, 2022

by: WOPRAI

Edward White Maintained (ACET) at Strong Buy with Increased Target to $38 on, Dec 12th, 2022

by: WOPRAI

Joanne Wuensch Maintained (ABT) at Strong Buy with Increased Target to $125 on, Dec 12th, 2022

by: WOPRAI

Martin Yang Maintained (AAPL) at Buy with Decreased Target to $170 on, Dec 12th, 2022

by: WOPRAI

Kristine Liwag Maintained (TDG) at Buy with Decreased Target to $765 on, Dec 12th, 2022

by: WOPRAI

Kristine Liwag Upgraded (TDY) to Hold and Increased Target to $488 on, Dec 12th, 2022

by: WOPRAI

Patrick Donnelly Upgraded (TECH) to Strong Buy and Increased Target to $100 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (UPST) at Sell with Increased Target to $14 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Downgraded (ULTA) to Hold and Decreased Target to $508 on, Dec 12th, 2022

by: WOPRAI

Jim Duffy Upgraded (UAA) to Strong Buy and Increased Target to $12 on, Dec 12th, 2022

by: WOPRAI

Andrew Obin Downgraded (TT) to Sell on, Dec 12th, 2022

by: WOPRAI

Brooke Roach Upgraded (TPR) to Strong Buy and Increased Target to $44 on, Dec 12th, 2022

by: WOPRAI

Vikram Purohit Maintained (TIL) at Hold with Decreased Target to $40 on, Dec 12th, 2022

by: WOPRAI

Brooke Roach Maintained (TJX) at Hold with Increased Target to $84 on, Dec 12th, 2022

by: WOPRAI

Kate McShane Maintained (TSCO) at Strong Buy with Increased Target to $238 on, Dec 12th, 2022

by: WOPRAI

Bert Subin Maintained (SNDR) at Strong Buy with Increased Target to $30 on, Dec 12th, 2022

by: WOPRAI

Julien Dumoulin-Smith Downgraded (SR) to Sell and Decreased Target to $61 on, Dec 12th, 2022

by: WOPRAI

Dan Dolev Maintained (SQ) at Hold with Increased Target to $70 on, Dec 12th, 2022

by: WOPRAI

Christopher Rolland Initiated (STM) at Buy and Held Target at $50 on, Dec 12th, 2022

by: WOPRAI

Larry Biegelsen Maintained (SYK) at Buy with Increased Target to $281 on, Dec 12th, 2022

by: WOPRAI

Peter Lawson Maintained (BPMC) at Hold with Decreased Target to $53 on, Dec 12th, 2022

by: WOPRAI

Pinjalim Bora Upgraded (BOX) to Buy and Increased Target to $34 on, Dec 12th, 2022

by: WOPRAI

Brooke Roach Maintained (BURL) at Strong Buy with Increased Target to $225 on, Dec 12th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (BWAY) at Strong Buy with Decreased Target to $13 on, Dec 12th, 2022

Joseph Thome Initiated (ACRV) at Buy on, Dec 12th, 2022

Joseph Thome of Cowen & Co., Initiated "Acrivon Therapeutics, Inc." (ACRV) at Buy on, Dec 12th, 2022.

Joseph, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30